Home › Stocks › GLUE › All Fund Holders
GLUE — MONTE ROSA THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 41 · Reported value held: $508.34M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 6.84M | $165.60M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 3.25M | $50.91M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 1.86M | $45.12M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 1.59M | $38.57M | 0.03% | Add |
| Goldman Sachs Group history | Q2 2026 | 998.25K | $24.16M | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q2 2026 | 934.41K | $22.61M | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 789.54K | $19.11M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 652.09K | $15.78M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 616.31K | $14.91M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 520.65K | $12.60M | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 685.93K | $11.29M | 0.01% | New |
| Arrowstreet Capital history | Q1 2026 | 647.74K | $10.66M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 254.56K | $6.16M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 222.52K | $5.39M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 207.43K | $5.02M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 200.83K | $4.86M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 198.90K | $4.81M | 0.01% | Reduce |
| Manulife Financial history | Q2 2026 | 191.88K | $4.64M | 0.00% | Reduce |
| Franklin Resources history | Q2 2026 | 188.83K | $4.57M | 0.00% | Reduce |
| Casdin Capital history | Q2 2026 | 186.01K | $4.50M | 0.23% | Hold |
| Citadel Advisors history | Q2 2026 | 172.37K | $4.17M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 172.05K | $4.16M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 140.92K | $3.41M | 0.00% | Add |
| Millennium Management history | Q1 2026 | 191.38K | $3.15M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 129.47K | $3.13M | 0.00% | Add |
| Norges Bank Investment Management history | Q4 2024 | 445.87K | $3.09M | 0.00% | New |
| Renaissance Technologies history | Q2 2026 | 102.50K | $2.48M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 97.01K | $2.35M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 76.82K | $1.84M | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 75.06K | $1.82M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 68.65K | $1.66M | 0.00% | Add |
| MFS Investment Management history | Q2 2026 | 54.33K | $1.31M | 0.00% | Reduce |
| Principal Global Investors history | Q2 2026 | 49.00K | $1.19M | 0.00% | Add |
| CPP Investments history | Q4 2025 | 68.10K | $1.07M | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 40.38K | $977.10K | 0.00% | Add |
| Point72 Asset Management history | Q3 2025 | 90.42K | $670.00K | 0.00% | New |
| Prudential Financial history | Q2 2026 | 11.97K | $289.80K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 8.86M | $214.44K | 0.02% | Add |
| Royce & Associates history | Q3 2025 | 11.02K | $81.69K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 457 | $11.06K | 0.00% | Hold |
| Lazard Asset Management history | Q2 2025 | 10.86K | $48 | 0.00% | Add |